Dacarbazine (DTIC) in malignant melanoma: Reduced toxicity with protection from light
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Clinical Radiology
- Vol. 32 (1) , 53-55
- https://doi.org/10.1016/s0009-9260(81)80251-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- A device to prevent photodegradation of dacarbazine (DTIC)Clinical Radiology, 1980
- PHOTODEGRADATION OF DACARBAZINEThe Lancet, 1978
- Adjuvant chemotherapy in the management of primary malignant melanomaCancer, 1978
- Chemotherapy of advanced soft-tissue sarcomas in adultsCancer Treatment Reviews, 1977
- Imidazole Carboxamide (DTIC) in the Treatment of Advanced LymphomasActa Haematologica, 1977
- A controlled clinical trial of fluorouracil plus imidazole carboxamide dimethyl triazeno plus vincristine plus bis-chloroethyl nitrosourea plus radiotherapy in stomach cancerMedical and Pediatric Oncology, 1976
- Combination chemotherapy with adriamycin (NSC‐123127) and dimethyl triazeno imidazole carboxamide (DTIC) (NSC‐45388) in children with metastatic solid tumorsMedical and Pediatric Oncology, 1976
- Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancerCancer, 1974
- Characteristics of prognosis and response to an imidazole carboxamide in malignant melanomaClinical Pharmacology & Therapeutics, 1971
- Imidazoles. I. Coupling Reactions of 5-Diazoimidazole-4-carboxamide1,2The Journal of Organic Chemistry, 1962